[Dynamic assessment of WT1 for predicting the relapse of acute myeloid leukemia patients with MLL rearrangements after hematopoietic stem cell transplantation].
作者信息
Liu X X, Kong J, Pan S A, Liu J, Qin Y Z, Chang Y J, Wang Y, Zhang X H, Xu L P, Huang X J, Zhao X S
机构信息
Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2022 Sep 14;43(9):785-787. doi: 10.3760/cma.j.issn.0253-2727.2022.09.013.
Abstract
摘要
相似文献
1
[Dynamic assessment of WT1 for predicting the relapse of acute myeloid leukemia patients with MLL rearrangements after hematopoietic stem cell transplantation].[动态评估WT1用于预测造血干细胞移植后MLL重排的急性髓系白血病患者的复发情况]
Zhonghua Xue Ye Xue Za Zhi. 2022 Sep 14;43(9):785-787. doi: 10.3760/cma.j.issn.0253-2727.2022.09.013.
2
Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome.移植后 MLL-PTD 的监测作为微小残留病可以预测急性髓系白血病和骨髓增生异常综合征患者异基因 HSCT 后的复发。
BMC Cancer. 2022 Jan 3;22(1):11. doi: 10.1186/s12885-021-09051-5.
3
Wilms' tumor gene 1 transcript levels in leukapheresis of peripheral blood hematopoietic cells predict relapse risk in patients autografted for acute myeloid leukemia.外周血造血细胞白细胞分离术中肾母细胞瘤基因1转录水平可预测急性髓系白血病自体移植患者的复发风险。
Biol Blood Marrow Transplant. 2014 Oct;20(10):1586-91. doi: 10.1016/j.bbmt.2014.06.017. Epub 2014 Jun 18.
4
Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.诊断时WT1转录水平低预示着接受化疗或异基因造血干细胞移植的t(8;21)急性髓系白血病患者预后不良。
Chin J Cancer. 2016 May 19;35:46. doi: 10.1186/s40880-016-0110-6.
5
WT1 Measurable Residual Disease Assay in Patients With Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation: Optimal Time Points, Thresholds, and Candidates.WT1 可测量残留病检测在接受异基因造血干细胞移植的急性髓系白血病患者中的应用：最佳时间点、阈值和候选者。
Biol Blood Marrow Transplant. 2019 Oct;25(10):1925-1932. doi: 10.1016/j.bbmt.2019.05.033. Epub 2019 Jun 4.
6
Wilms' tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.Wilms' 肿瘤基因 1 是异基因造血干细胞移植后儿童急性髓系白血病的独立预后因素。
BMC Cancer. 2021 Mar 19;21(1):292. doi: 10.1186/s12885-021-08022-0.
7
Efficacy of myeloablative allogeneic hematopoietic stem cell transplantation in adult patients with MLL-ELL-positive acute myeloid leukemia.清髓性异基因造血干细胞移植治疗MLL-ELL阳性成年急性髓系白血病患者的疗效
Int J Hematol. 2015 Jul;102(1):86-92. doi: 10.1007/s12185-015-1779-z. Epub 2015 Mar 11.
8
Monitoring mixed lineage leukemia expression may help identify patients with mixed lineage leukemia--rearranged acute leukemia who are at high risk of relapse after allogeneic hematopoietic stem cell transplantation.监测混合谱系白血病的表达可能有助于识别混合谱系白血病重排急性白血病患者，这些患者在异基因造血干细胞移植后有高复发风险。
Biol Blood Marrow Transplant. 2014 Jul;20(7):929-36. doi: 10.1016/j.bbmt.2014.03.008. Epub 2014 Mar 13.
9
WT1 and TP53 as valuable diagnostic biomarkers for relapse after hematopoietic stem cell transplantation in acute myeloid leukemia.WT1 和 TP53 作为急性髓细胞白血病造血干细胞移植后复发的有价值的诊断生物标志物。
Mol Biol Rep. 2024 Feb 1;51(1):244. doi: 10.1007/s11033-023-09185-8.
10
WT1-guided pre-emptive therapy after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia.WT1 指导的异基因造血干细胞移植后急性髓系白血病的抢先治疗。
Int J Hematol. 2024 Sep;120(3):337-346. doi: 10.1007/s12185-024-03795-z. Epub 2024 May 25.
本文引用的文献
1
Wilms' tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.Wilms' 肿瘤基因 1 是异基因造血干细胞移植后儿童急性髓系白血病的独立预后因素。
BMC Cancer. 2021 Mar 19;21(1):292. doi: 10.1186/s12885-021-08022-0.
2
Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后频繁 11q23 重排急性白血病的微小残留病监测和抢先免疫治疗。
Ann Hematol. 2021 May;100(5):1267-1281. doi: 10.1007/s00277-021-04488-x. Epub 2021 Mar 13.
3
The predictive value of minimal residual disease when facing the inconsistent results detected by real-time quantitative PCR and flow cytometry in NPM1-mutated acute myeloid leukemia.在实时定量聚合酶链反应和流式细胞术检测到 NPM1 突变的急性髓系白血病结果不一致的情况下，微小残留病的预测价值。
Ann Hematol. 2020 Jan;99(1):73-82. doi: 10.1007/s00277-019-03861-1. Epub 2019 Nov 25.
4
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.成人急性髓系白血病的诊断与管理：2017年国际专家小组的欧洲白血病网络（ELN）建议
Blood. 2017 Jan 26;129(4):424-447. doi: 10.1182/blood-2016-08-733196. Epub 2016 Nov 28.
5
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.2016 年版世界卫生组织髓系肿瘤和急性白血病分类。
Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.
6
Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study.缓解期 AML 患者接受 HLA 单倍体相合与同胞全相合移植的前瞻性多中心研究
Blood. 2015 Jun 18;125(25):3956-62. doi: 10.1182/blood-2015-02-627786. Epub 2015 May 4.
7
Monitoring mixed lineage leukemia expression may help identify patients with mixed lineage leukemia--rearranged acute leukemia who are at high risk of relapse after allogeneic hematopoietic stem cell transplantation.监测混合谱系白血病的表达可能有助于识别混合谱系白血病重排急性白血病患者，这些患者在异基因造血干细胞移植后有高复发风险。
Biol Blood Marrow Transplant. 2014 Jul;20(7):929-36. doi: 10.1016/j.bbmt.2014.03.008. Epub 2014 Mar 13.
8
Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity.联合使用 WT1 和流式细胞术监测可以提高异基因 HSCT 后预测复发的敏感性，而不影响特异性。
Ann Hematol. 2013 Aug;92(8):1111-9. doi: 10.1007/s00277-013-1733-1. Epub 2013 May 17.
9
Wilms' tumor gene 1 expression: an independent acute leukemia prognostic indicator following allogeneic hematopoietic SCT.Wilms 瘤基因 1 表达：异基因造血干细胞移植后急性白血病的独立预后指标。
Bone Marrow Transplant. 2012 Apr;47(4):499-507. doi: 10.1038/bmt.2011.121. Epub 2011 Jun 6.
10
Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease.WT1和PRAME在急性髓系白血病患者中的表达模式及其在监测微小残留病中的应用价值。
Leuk Res. 2009 Mar;33(3):384-90. doi: 10.1016/j.leukres.2008.08.026. Epub 2008 Oct 23.
Zotero 插件